Bipolar Radiofrequency Ablation Plus Argon Beam Coagulator Ablation for Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT02424110

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02424110
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02424110. Randomized; double masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2018-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bipolar Radiofrequency Ablation Plus Argon Beam Coagulator Ablation for Atrial Fibrillation
Intervention (Procedure)
argon beam coagulator ablation
Intervention (Procedure)
bipolar radiofrequency ablation
Intervention (Device)
argon beam coagulator (American,Valleylab)
Intervention (Device)
bipolar radiofrequency (AtricuteTM)
Lead sponsor
Xinqiao Hospital of Chongqing (class: other)

Record details

Record id
cardio:ct-nct02424110
Content hash
b5c9146812c9c5a2aba16759c4230029582ce956a212191170f908fc7c132093